Cells for Cells S.A. is a Chilean-based biotech company founded in 2010. The company focuses on the research, development, and commercialization of cell therapies and tissue-engineered solutions. With a diverse portfolio of over 10 technologies, including Cellistem®OA, Inkure®, Oxium®Exo, and Veintis™, the company has made a mark in the biotechnology industry. As a spin-off from Universidad de los Andes, Chile, Cells for Cells has the advantage of leveraging academic research and expertise.
There is no investment information
No recent news or press coverage available for Cells for Cells.